The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease
about
An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.New answers to old conundrums: what antibodies, exosomes and inflammasomes bring to the conversation. Canadian National Transplant Research Program international summit report.Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.From genetic single candidate gene studies to complex genomics of GvHD.PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.Extrafollicular CD4+ T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease.Clinical significance of IgE in a large cohort of patients with moderate or severe chronic graft-versus-host disease.Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned.An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.Biomarkers in chronic graft-versus-host disease: quo vadis?The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia.Patients with Treatment-Requiring Chronic Graft versus Host Disease after Allogeneic Stem Cell Transplantation Have Altered Metabolic Profiles due to the Disease and Immunosuppressive Therapy: Potential Implication for Biomarkers.OMIP-042: 21-color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood.Acute graft-versus-host disease of the gut: considerations for the gastroenterologist.Chronic Graft-versus-Host Disease: A Long Road Ahead.Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.Cytokine mediators of chronic graft-versus-host disease.Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease.Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence.Unraveling the Mechanisms of Cutaneous Graft-Versus-Host Disease.Patient-reported outcomes and health status associated with chronic graft--host diseaseHow ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD
P2860
Q33798102-60474C08-0416-47EB-B999-56F2896E6A55Q38668025-270EE2ED-B26D-4AB4-80B0-BF44E2B033FFQ38932342-E9FB87AE-8BC3-4D8D-8FB8-69DA3A760CBDQ39263959-A04838D5-9EE3-4EC6-B3F4-A3573689B411Q40354412-4DEA815E-1DDF-472D-AE66-4275D067ACACQ42379668-090EC4B8-0A8D-444D-8F00-0AD4188401FCQ44014033-CB3002E9-263A-4F81-8225-9C993E177AD3Q45873930-B571FE27-DDD4-43BA-B071-B2F6D1A249A3Q47709978-1DB453EE-B0F1-4B4C-812E-C65ECA107A06Q47713449-00BC4AEE-CC2F-4EE8-8ADD-57513257F15EQ49384876-1796C9F3-EF17-4DA3-9DC6-05835D5E1C57Q49464975-3215FD78-DE6C-4068-97D0-DA2912C444CEQ49483136-9A0B912D-9058-4F60-9CA2-DBFDE47DE5ABQ49806345-D72F77BD-074E-427B-A800-5653EE322D2FQ49900740-FFA35BAE-1B98-4C5F-AAEA-7E6580F5E849Q49954477-87C694B7-29DF-4C93-8890-6F896C3A9B03Q50915048-EE6E8DE0-3A18-47D2-88E1-046E14C16A15Q51028682-136EA62F-6F57-4BCF-B505-BC4DA2CB2BE3Q55045366-9863B8A0-5C37-4F92-B79C-58A8A74855F9Q55375763-B6C4A2CD-9B0A-4D02-BBFF-A4648E856C29Q58777001-D5D196DC-15CC-462C-836D-408049AF3067Q58782275-E61776A9-0F06-43A8-9977-347E1A0BFC65
P2860
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The Biology of Chronic Graft-v ...... onic Graft-versus-Host Disease
@ast
The Biology of Chronic Graft-v ...... onic Graft-versus-Host Disease
@en
The Biology of Chronic Graft-v ...... onic Graft-versus-Host Disease
@nl
type
label
The Biology of Chronic Graft-v ...... onic Graft-versus-Host Disease
@ast
The Biology of Chronic Graft-v ...... onic Graft-versus-Host Disease
@en
The Biology of Chronic Graft-v ...... onic Graft-versus-Host Disease
@nl
prefLabel
The Biology of Chronic Graft-v ...... onic Graft-versus-Host Disease
@ast
The Biology of Chronic Graft-v ...... onic Graft-versus-Host Disease
@en
The Biology of Chronic Graft-v ...... onic Graft-versus-Host Disease
@nl
P2093
P2860
P50
P1476
The Biology of Chronic Graft-v ...... onic Graft-versus-Host Disease
@en
P2093
Daniel H Fowler
David B Miklos
Frances T Hakim
Georgia Vogelsang
Jerome Ritz
Kenneth R Cooke
Leo Luznik
Madan Jagasia
Marcel R M van den Brink
Paul J Martin
P2860
P304
P356
10.1016/J.BBMT.2016.09.023
P407
P577
2016-10-03T00:00:00Z